What is Zimmer Biomet Holdings Inc Annual Revenue?

Zimmer Biomet Holdings Inc Annual Revenue rose 3.85%, in the last year to $7,678.6 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

What is Zimmer Biomet Holdings Inc Annual Net Profit?

Zimmer Biomet Holdings Inc Annual Net Profit fell 11.74% in the last year to $903.8 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

What is Zimmer Biomet Holdings Inc Price to Earning Ratio?

Zimmer Biomet Holdings Inc Price to Earning Ratio is 21.33, lower than its sector PE ratio of 29.32.

What is Zimmer Biomet Holdings Inc Stock Price?

Zimmer Biomet Holdings Inc Stock Price fell 18.41% and underperformed its sector by 26.12% in the past year.

What is Zimmer Biomet Holdings Inc Quarterly Revenue?

Zimmer Biomet Holdings Inc Quarterly Revenue rose 4.28% YoY to $2,023.2 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

What is Zimmer Biomet Holdings Inc Quarterly Net profit?

Zimmer Biomet Holdings Inc Quarterly Net profit fell 42.87% YoY to $239.5 M. Its sector's average net profit growth YoY for the quarter was 32.9%.

What is Zimmer Biomet Holdings Inc Debt to Equity Ratio?

Zimmer Biomet Holdings Inc Debt to Equity Ratio of 0.5 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Zimmer Biomet Holdings Inc Return on Equity(ROE)?

Zimmer Biomet Holdings Inc Return on Equity(ROE) for the last financial year was 7.25%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Zimmer Biomet Holdings Inc Mutual Fund Holding?

Zimmer Biomet Holdings Inc Mutual Fund Holding increased by 1.24% in the last quarter to 86.59.

What is Zimmer Biomet Holdings Inc Promoter Share Holding?

Zimmer Biomet Holdings Inc Promoter Share Holding increased by 0.04% in the most recent quarter to 0.12%.

What is Zimmer Biomet Holdings Inc Interest Coverage Ratio?

Zimmer Biomet Holdings Inc Interest Coverage Ratio is 5.76, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Zimmer Biomet Holdings Inc Institutional Holding?

Zimmer Biomet Holdings Inc Institutional Holding increased by 0.24% in the last quarter to 92.46.

How is the Zimmer Biomet Holdings Inc today?

The Zimmer Biomet Holdings Inc today is trading in the green, up by 1.32% at 97.44.

How has Zimmer Biomet Holdings Inc performed historically?

The Zimmer Biomet Holdings Inc is currently trading up 1.32% on an intraday basis in the past week the index fell -4.44%. The index has been down -11.83% in the past quarter and fell -18.41% in the past year. You can view this in the overview section.

Zimmer Biomet Holdings Inc XNYS: ZBH

Zimmer Biomet Holdings Inc Live Share Price Today, Share Analysis and Chart

Name: Zimmer Biomet Holdings Inc: Is Infosys Ltd. worth buying?
Item: Zimmer Biomet Holdings Inc
Rating: 2.417541625
Author: Trendlyne DVM scores

Mid-range Performer

Download real time

97.44 1.27 (1.32%)

New 52W Low in past week

1.4M XNYS Volume

XNYS 22 Apr, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Zimmer Biomet Holdings Inc is on 02 May 2025 for the purpose of Zimmer Biomet Holdings Inc First Quarter Earnings Results for 2025 See details

Zimmer Biomet Holdings Inc Key Metrics

My Metrics

Default

Market Capitalization High in industry Unavailable in chosen country	19,277.7
PE TTM Below industry Median Unavailable in chosen country	21.3
PEG TTM Negative PEG TTM Unavailable in chosen country	-1.8
Price to Book Below industry Median Unavailable in chosen country	1.5
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	92.5
Revenue Growth Qtr YoY % Below industry Median Unavailable in chosen country	4.3
Operating Revenue growth TTM % Below industry Median Unavailable in chosen country	3.8
Net Profit Qtr Growth YoY % Negative Net Profit Qtr Growth YoY % Unavailable in chosen country	-42.9
Net Profit TTM Growth % Negative Net Profit TTM Growth % Unavailable in chosen country	-11.7
Operating Profit Margin Qtr % High in industry Unavailable in chosen country	20.9
Operating Profit Margin TTM % High in industry Unavailable in chosen country	19.9
Piotroski Score High in industry Unavailable in chosen country	7
Rel Perf vs Sector quarter% Unavailable in chosen country	-3.1
ROE Annual % Below industry Median Unavailable in chosen country	7.2
RoA Annual % Below industry Median Unavailable in chosen country	4.2

All financials are in USD Million and price data in USD

Medium Financial Strength

50.0 / 100

Affordable Valuation

57.8 / 100

Technically Neutral

35.6 / 100

Mid-range Performer These stocks may be affordable or expensive, based on their medium quality and mid-range technical score. However, their reasonable financials are successful in gathering some investor interest. View Similar Embed DVM

122

1Yr Price target upside is 26%

26 analysts

Check Before You Buy

Check P/E Buy Sell Zone

Strong Buy Zone

16.0 % into P/E buy sell zone

Strong upside potential

% time spent below current P/E

Gains already realized

Zimmer Biomet Holdings Inc Stock Price Analysis

Day Price Range 1.3% 1 Day return Unavailable in chosen country	97.4 (LTP) 95.897.6 LowHigh
Week Price Range -4.4% 1 Week return Unavailable in chosen country	97.4 (LTP) 93.1102.1 LowHigh
Month Price Range -12.0% 1 Month return Unavailable in chosen country	97.4 (LTP) 93.1114.4 LowHigh
52 Week Price Range -18.4% 1 Year return Unavailable in chosen country	97.4 (LTP) 93.1123.9 LowHigh

View full Share Price History

Zimmer Biomet Holdings Inc Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Hit

Zimmer Biomet Holdings Inc's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

4.4

Avg. Estimate

4.9

Low Estimate

3.7

High Estimate

6.1

Current EPS

Avg. Estimate

Hit

EPS is expected to grow by 9.5% in FY25

Consensus Recommendation

30 ANALYST Recommendations

HOLD

The consensus recommendation from 30 analysts for Zimmer Biomet Holdings Inc is HOLD

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Zimmer Biomet Holdings Inc Stock Analysis

Zimmer Biomet Holdings Inc stock analysis with key metrics, changes, and trends.

Zimmer Biomet Holdings Inc Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$7,678.6 M	3.85%	positive	Annual Revenue rose 3.85%, in the last year to $7,678.6 M. Its sector's average revenue growth for the last fiscal year was 8.57%.
Annual Net Profit	$903.8 M	11.74%	negative	Annual Net Profit fell 11.74% in the last year to $903.8 M. Its sector's average net profit growth for the last fiscal year was 4.36%.
Price to Earning Ratio	21.33	-	positive	Price to Earning Ratio is 21.33, lower than its sector PE ratio of 29.32.
Stock Price	$97.44	-18.41%	negative	Stock Price fell 18.41% and underperformed its sector by 26.12% in the past year.
Quarterly Revenue	$2,023.2 M	4.28%	positive	Quarterly Revenue rose 4.28% YoY to $2,023.2 M. Its sector's average revenue growth YoY for the quarter was 8.5%.
Quarterly Net profit	$239.5 M	42.87%	negative	Quarterly Net profit fell 42.87% YoY to $239.5 M. Its sector's average net profit growth YoY for the quarter was 32.9%.
Debt to Equity Ratio	0.5	-	positive	Debt to Equity Ratio of 0.5 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	7.25 %	7.25%	negative	Return on Equity(ROE) for the last financial year was 7.25%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	86.59 %	1.24%	positive	Mutual Fund Holding increased by 1.24% in the last quarter to 86.59.
Promoter Share Holding	0.12 %	0.04%	positive	Promoter Share Holding increased by 0.04% in the most recent quarter to 0.12%.
Interest Coverage Ratio	5.76	-	positive	Interest Coverage Ratio is 5.76, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
Institutional Holding	92.46 %	0.24%	positive	Institutional Holding increased by 0.24% in the last quarter to 92.46.

VIEW LESS

Loading data..

Zimmer Biomet Holdings Inc - Company Profile

What does Zimmer Biomet Holdings Inc do?

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

2024

Gross Remuneration

Year

Zimmer Biomet Holdings Inc Live Share Price Today, Share Analysis and Chart

New 52W Low in past week

Zimmer Biomet Holdings Inc Key Metrics

Market Capitalization

PE TTM

PEG TTM

Rel Perf vs Sector quarter%

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

ROE Annual %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

RoA Annual %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Zimmer Biomet Holdings Inc Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Zimmer Biomet Holdings Inc Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Zimmer Biomet Holdings Inc's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

EPS is expected to grow by 9.5% in FY25

Consensus Recommendation

The consensus recommendation from 30 analysts for Zimmer Biomet Holdings Inc is HOLD

Zimmer Biomet Holdings Inc Stock Analysis

Zimmer Biomet Holdings Inc stock analysis with key metrics, changes, and trends.

Annual Revenue rose 3.85%, in the last year to $7,678.6 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

Annual Net Profit fell 11.74% in the last year to $903.8 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

Price to Earning Ratio is 21.33, lower than its sector PE ratio of 29.32.

Stock Price fell 18.41% and underperformed its sector by 26.12% in the past year.

Quarterly Revenue rose 4.28% YoY to $2,023.2 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

Quarterly Net profit fell 42.87% YoY to $239.5 M. Its sector's average net profit growth YoY for the quarter was 32.9%.

Debt to Equity Ratio of 0.5 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was 7.25%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding increased by 1.24% in the last quarter to 86.59.

Promoter Share Holding increased by 0.04% in the most recent quarter to 0.12%.

Interest Coverage Ratio is 5.76, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding increased by 0.24% in the last quarter to 92.46.

Zimmer Biomet Holdings Inc - Company Profile

What does Zimmer Biomet Holdings Inc do?

Zimmer Biomet Holdings Inc Management structure

Mr. Ivan Tornos

Director, President and Chief Executive Officer

Mr. Suketu Upadhyay

Chief Financial Officer and Executive Vice President, Finance, Operations and Supply Chain

Mr. Wilfred van Zuilen

Group President, Europe, Middle East and Africa

Mr. Sang Yi

Group President, Asia Pacific

Mr. Mark Bezjak

President, Americas

Mr. Chad F. Phipps

Senior Vice President, General Counsel and Secretary

Zimmer Biomet Holdings Inc Board of directors

Mr. Christopher B. Begley